(Reuters) - Allergan Inc , which is fighting a $51 billion hostile takeover bid from Valeant Pharmaceuticals International and activist investor William Ackman, on Friday filed a federal lawsuit alleging they violated insider trading laws and engaged in other fraudulent practices. (Reporting by Ransdell Pierson)